This website provides structured, medically reviewed, evidence‑based information about Dapoxetine (Priligy), a short‑acting SSRI developed specifically for premature ejaculation (PE). Our goal is to deliver clear, clinically accurate, and responsibly curated content that helps readers understand how Dapoxetine works, its benefits, risks, and practical considerations.
We follow strict editorial and medical review standards to ensure accuracy, neutrality, and transparency. All clinical statements are supported by authoritative sources such as DrugBank, Europe PMC, and NCBI PMC. Our content is educational only and not a substitute for professional medical advice.
Key pages: Medical Review Policy • Editorial Policy • Privacy Policy • Terms of Use • Contact
Our mission is to provide reliable, accessible, and clinically accurate information about Dapoxetine and premature ejaculation. We focus on clarity, neutrality, and evidence‑based medical communication. Every page is designed to help readers understand the medication, its mechanism, safety considerations, and practical use cases.
All medical content is developed using authoritative clinical sources and undergoes a multi‑step review process:
You can learn more about our standards here: Medical Review Policy and Editorial Policy.
Our Dapoxetine knowledge base is organized into clear, medically relevant sections to help readers navigate specific topics easily:
Explore the clinical cluster: Mechanism of Action • Pharmacokinetics • Dosage • Onset & Duration • Side Effects • Warnings • Interactions • Contraindications • Clinical Evidence • PE Pathophysiology • Priligy vs Generic • Priligy vs SSRIs • Price Guide • FAQ
All clinical content is reviewed by qualified medical professionals with experience in sexual medicine, pharmacology, or evidence‑based medical writing. Learn more about our reviewers here: Medical Reviewer.
We maintain full transparency regarding our editorial process, data handling, and communication standards. For inquiries, corrections, or feedback, please visit: Contact Page.